Private Equity Firm Archimed To Buy ZimVie As Antitrust Concerns Sideline Strategic Buyers
Archimed will acquire dental implant firm ZimVie for $730m in a deal that reflects private equity’s growing role in medtech M&A, as strategic buyers face antitrust scrutiny. The deal includes a 125% premium and a 40-day window for competing offers.